Aireen

Hlavní město Praha, Czechia

Aireen is an innovative AI-powered medical device dedicated to transforming how healthcare providers detect and manage serious diseases. By leveraging human retina and advanced neural network models, Aireen enables autonomous, precise screening for conditions such as diabetic retinopathy (DR), age-related macular degeneration (AMD), cardiovascular diseases, and neurodegenerative disorders. Why Aireen? Diabetic retinopathy alone affects nearly 30% of the global diabetic population, and with over 537 million people living with diabetes today—a number projected to reach 783 million by 2045—the need for accurate, scalable screening solutions has never been greater. Early detection is key to preventing severe complications like vision loss. Aireen empowers healthcare providers by offering fast, reliable AI-driven analysis without the need for manual interpretation, ensuring critical conditions are identified at their earliest stages.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Aireen on @MedStartr Today #MedMo #MedStartrVentures

https://www.medstartr.ai/s/vF1S3aGW_RI

Get Involved in Aireen

Company Info

Founded: 2018
Website: www.aireen.com/

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Aireen?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.